AdvaMed: AdvaMed warns of device cost increases and patient harm from tariffs

AdvaMed is again seeking a medical device exemption from the Trump Administration's new import taxes, warning that the tariffs could cause supply chain disruptions that will increase prices, reduce access to treatment and force patients to wait longer for care. The medical device industry association and nine other health care groups wrote a letter to...The post AdvaMed warns of device cost increases and patient harm from tariffs appeared first on Medical Design and Outsourcing.